News & Events
Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing
Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals
Establishing a lead position in Taiwan’s CDMO sector
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market
Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals...
Bora Pharmaceuticals to expand operations with $10m investment
TAIWAN – Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a...
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan
TAIPEI, Taiwan, Dec. 3, 2021 /PRNewswire/ -- Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced...
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan
Taipei, Taiwan, August 5, 2021 KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has...
Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023
Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023Bora has been awarded...
CEO Bobby Sheng wins CEO of the Year at CPhI Awards 2020
CEO Bobby Sheng wins CEO of the Year at CPhI Awards 2020Bora Pharmaceuticals, a full-service contract development and...